Cipla Pharmaceuticals Limited

Cipla Pharmaceuticals Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U24239MH2019PLC333266 Incorporated 19 November 2019 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹2.19 Cr
▼ 19.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹190 Cr
Registered with MCA
Paid-up capital
₹170 Cr
Issued & subscribed
Open charges
None
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
61
Latest available

About Cipla Pharmaceuticals Limited

Data last updated: 20 December 2025

Cipla Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Cipla Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 19 November 2019, the company has been in operation for over 7 years.

Registered with ROC Mumbai under CIN U24239MH2019PLC333266.

Capital: an authorised share capital of ₹190 Cr and a paid-up capital of ₹170 Cr. It is led by directors including Dinesh Ramniranjan Jain and Naveen Kapil.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Tower A 1St Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.19 Cr, a decline of 19% compared to the previous year.

The company has a workforce of approximately 61 employees as per the latest available data. It operates as a subsidiary of Cipla Limited.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cipla.com.

Company Details of Cipla Pharmaceuticals Limited
CIN U24239MH2019PLC333266
Registration Number 333266
Incorporation Date 19 November 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Cipla Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    Tower A 1St Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013
  • Industry
    Pharma, Drug Formulation & Development
Company report
Cipla Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Cipla Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Cipla Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

Auditor Details of Cipla Pharmaceuticals Limited

Cipla Pharmaceuticals Limited is audited by Walker Chandiok & Co LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Walker Chandiok & Co LLP Locked Locked Locked
Premium access

Complete auditor history for Cipla Pharmaceuticals Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Cipla Pharmaceuticals Limited

Cipla Pharmaceuticals Limited is currently managed by 4 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Dinesh Ramniranjan Jain Director 19 Nov 2019 6 Years 8 Months Current
Naveen Kapil Managing Director 13 Mar 2025 1 Years 5 Months Current
Rajendra Kumar Chopra Director 19 Nov 2019 6 Years 8 Months Current
Raju Sunil Mistry Additional Director 23 Jul 2025 1 Years 0 Months Current

Financials of Cipla Pharmaceuticals Limited FY 2025 filings available

Cipla Pharmaceuticals Limited reported revenue of ₹2.19 Cr (down 19.00% YoY) for FY 2025.

Revenue · FY 2025
₹2.19 Cr ▼ 19.00%
Premium access

Ten-year financial statements for Cipla Pharmaceuticals Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Cipla Pharmaceuticals Limited

Premium access

Shareholding and ownership data for Cipla Pharmaceuticals Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings Cipla Pharmaceuticals Limited

Cipla Pharmaceuticals Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Cipla Pharmaceuticals Limited

Cipla Pharmaceuticals Limited has a workforce of 61 employees as of Apr 07, 2025.

Employee count
61
Active EPFO establishments
1
Employee growth
454.55%
Premium access

Employee and EPFO history for Cipla Pharmaceuticals Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Cipla Pharmaceuticals Limited

Premium access

GST registrations and filing compliance for Cipla Pharmaceuticals Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Cipla Pharmaceuticals Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Cipla Pharmaceuticals Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Cipla Pharmaceuticals Limited

Premium access

MSME payment history for Cipla Pharmaceuticals Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Cipla Pharmaceuticals Limited

Premium access

Corporate group structure for Cipla Pharmaceuticals Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Cipla Pharmaceuticals Limited

Premium access

MCA filings and documents for Cipla Pharmaceuticals Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Cipla Pharmaceuticals Limited

Activity
30 Sep 2025
Cipla Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Directors
23 Jul 2025
Raju Sunil Mistry was appointed as a Additional Director on 23 Jul 2025 & has been associated with this company since 1 year 21 days.
Activity
31 Mar 2025
Cipla Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
13 Mar 2025
Naveen Kapil was appointed as a Managing Director on 13 Mar 2025 & has been associated with this company since 1 year 5 months.
Directors
24 Aug 2023
Anil Kumar Choudhary was appointed as a CFO on 24 Aug 2023 & has been associated with this company since 2 years 11 months.
Directors
09 May 2020
Rahul Verma was appointed as a Company Secretary on 09 May 2020 & has been associated with this company since 6 years 3 months.

Frequently Asked Questions about Cipla Pharmaceuticals Limited

Cipla Pharmaceuticals Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 19 November 2019 (7+ years old) and is registered under CIN U24239MH2019PLC333266. The company has 61 employees.

Cipla Pharmaceuticals Limited reported revenue of ₹2.19 Cr for FY 2025 (down 19.00% YoY).

The current directors of Cipla Pharmaceuticals Limited are:

The primary industry of Cipla Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Cipla Pharmaceuticals Limited can be reached at the registered office: Tower A 1St Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013, or through the website cipla.com.

The authorised capital is ₹190 Cr, and the paid-up capital is ₹170 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available